First American Bank’s Novartis NVS Stock Holding History

First American Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-49,560	Closed	-$3.82M	–	298
2015 Q4	$3.82M	Sell	49,560 -950	-2%	-$75.5K	0.39%	55
2015 Q3	$4.16M	Buy	50,510 +745	+1%	+$66.3K	0.46%	49
2015 Q2	$4.38M	Sell	49,765 -5,050	-9%	-$463K	0.43%	56
2015 Q1	$4.84M	Buy	54,815 +932	+2%	+$82.7K	0.48%	54
2014 Q4	$4.47M	Buy	53,883 +308	+0.6%	+$25.5K	0.47%	54
2014 Q3	$4.52M	Buy	53,575 +2,151	+4%	+$174K	0.49%	50
2014 Q2	$4.17M	Sell	51,424 -54	-0.1%	-$4.25K	0.45%	52
2014 Q1	$3.92M	Buy	51,478 +4,692	+10%	+$342K	0.43%	54
2013 Q4	$3.37M	Buy	46,786 +12,259	+36%	+$852K	0.39%	59
2013 Q3	$2.37M	Buy	34,527 +3,521	+11%	+$233K	0.29%	67
2013 Q2	$1.96M	Buy	+31,006	New	+$2.02M	0.27%	70

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

First American Bank's NVS Position: Q1 2016 in Review

First American Bank sold out of Novartis (NVS) in Q1 2016, closing a stake of 49,560 shares — an estimated $3.82M sold.

First American Bank first reported a position in NVS in Q2 2013 and held it in 11 quarters. The position peaked at $4.84M in Q1 2015. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

First American Bank reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
First American Bank sold 49,560 Novartis shares in Q1 2016, an estimated $3.82M.
First American Bank first reported a position in Novartis in Q2 2013 and held it in 11 quarters.
First American Bank's Novartis position peaked at $4.84M in Q1 2015.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on First American Bank's 13F filing for Q1 2016, filed 6 Apr 2016.